Your browser doesn't support javascript.
loading
Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted Immunotherapy.
Emerson, Dana A; Rolig, Annah S; Redmond, William L.
Afiliación
  • Emerson DA; Cell, Developmental, and Cancer Biology Department, Oregon Health and Science University, Portland, Oregon.
  • Rolig AS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.
  • Redmond WL; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.
Cancer Immunol Res ; 9(4): 430-440, 2021 04.
Article en En | MEDLINE | ID: mdl-33593794

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Receptores OX40 / Antígeno CTLA-4 / Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Receptores OX40 / Antígeno CTLA-4 / Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article